custom image

Asthma: New Discoveries and Therapies in the Age of COVID

December 1-2, 2020 | 10:00AM EST | 3:00PM UTC* 
*Program is in development subject to change


Asthma and related diseases in the form of COPD and asthma-COPD are a remarkably common, affecting over 50 million patients in the US alone. Moreover, this disease spectrum overlaps with inflammatory lung disease driven by respiratory viral infection, including COVID-19. In the case of asthma, the pathology is thought to arise from an aberrant type 2 immune response, but the cellular and molecular mechanisms of this response require more precise definition, including any contribution from non-type 2 immune mechanisms. Clinical trials based on these concepts have revealed both successes and also some unforeseen failures that need to be addressed and included in the framework of respiratory viruses in general and SARS-CoV-2 in particular. This Keystone Symposia conference on asthma will highlight the most recent basic science breakthroughs in the pathogenesis of asthma and related inflammatory airway diseases and focus on the development of new therapeutics for asthma and related progressive respiratory disease. In addition, the program will review these discoveries in the context of new therapeutic directions, including the context of emerging information about COVID-19. The program has been designed to emphasize to identify, validate, and translate new disease targets into new therapeutics. The topic is timely and urgent given the recent mechanistic insights into inflammatory airway disease, the current maturation of new biological therapies for this type of disease, and the overlap of this information with progressive lung disease after respiratory viral infections, including COVID-19.

Pricing:

Registration for this meeting is now closed.

Deadlines:

Abstract Submission
for Short Talk Consideration:
Passed
ePoster Abstract Submission: Passed
Financial Aid Application: Passed

#VKSAsthma21




Program Details



Speaking at this eSymposia


Karen Affleck

GlaxoSmithKline, UK


Rafeul Alam

National Jewish Health, USA


Joseph R. Arron

Genentech Inc., USA


Nora A. Barrett

Brigham and Women's Hospital, USA


Maria Belvisi

Imperial College London / AstraZeneca, UK



Jonathan Corren

University of California, Los Angeles, USA


David B. Corry

Baylor College of Medicine, USA


Jeffrey Haspel

Washington University in St. Louis, USA


Michael J. Holtzman

Washington University in St. Louis, USA


Elliot Israel

Harvard Medical School/Brigham & Women's Hospital, USA


Vijay K. Kuchroo

Brigham and Women's Hospital, Harvard Medical School, USA


Bart N. Lambrecht

VIB, Ghent University, Belgium


Clare M. Lloyd

Imperial College London, UK


Parameswaran Nair

McMaster University, Canada


Martijn C. Nawijn

University Medical Center Groningen, Netherlands


Bali Pulendran

Stanford University School of Medicine, USA


Anuradha Ray

University of Pittsburgh School of Medicine, USA


Alexander Scheffold

Christian-Albrechts-Universität zu Kiel, Germany


Anne I. Sperling

University of Chicago, USA


Jenny P.Y. Ting

University of North Carolina at Chapel Hill, USA


Prescott G. Woodruff

University of California, San Francisco, USA






Sponsors


 

sponsor-carousel-ionis.png

 




Additional Support



 

sponsor-carousel-bmgf.png

 

Funding for this conference was made possible (in part) by Grant No. 1 R13 HL152474-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.




Media-in-Kind Support


sponsor-carousel-jcb-jem.png

sponsor-carousel-embo.png

sponsor-carousel-frontiers.png

sponsor-carousel-scientist.png






The views expressed in this eSymposia are those of the participants and not necessarily of the participants’ organizations or of Keystone Symposia.






Related Keystone Symposia In-Person Meetings

Explore all cancer-related meetings on the Keystone Symposia website.

custom image

custom image

custom image






Donate to Keystone Symposia


custom image